As of April 16, 2025, Altimmune (ALT) has a market cap of $0.35 billion USD. According to our data, Altimmune is ranked No.6349 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.35 B |
-31.97%
|
Dec 31, 2024 | $0.51 B |
-35.91%
|
Dec 29, 2023 | $0.80 B |
-31.61%
|
Dec 30, 2022 | $1.17 B |
79.59%
|
Dec 31, 2021 | $0.65 B |
-18.79%
|
Dec 31, 2020 | $0.80 B |
496.83%
|
Dec 31, 2019 | $0.13 B |
-8.25%
|
Dec 31, 2018 | $0.15 B |
-96.55%
|
Dec 29, 2017 | $4.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Inovio Pharmaceuticals
INO
|
$64.55 M |
0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$81.11 M |
-0.000 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.42 B |
-0.000 M
|
![]() USA
|
![]() Arcturus Therapeutics
ARCT
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.73 B |
0.000 M
|
![]() Germany
|
![]() Telesis Bio
TBIO
|
$1.33 M |
0.000 M
|
![]() USA
|
![]() Vir Biotechnology
VIR
|
$0.77 B |
-0.000 M
|
![]() USA
|
![]() Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
![]() USA
|
![]() Ocugen
OCGN
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Emergent BioSolutions
EBS
|
$0.25 B |
0.000 M
|
![]() USA
|
![]() Tonix Pharmaceuticals
TNXP
|
$0.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | ALT Stock Price | * | ALT Shares Outstanding |
= | $4.53 | * | 77.01 M | |
= | $0.35 B |